Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3225) 3225
Newsletter (53) 53
Newspaper Article (51) 51
Magazine Article (45) 45
Book Chapter (16) 16
Dissertation (5) 5
Publication (3) 3
Streaming Video (2) 2
Conference Proceeding (1) 1
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (2774) 2774
humans (2724) 2724
science & technology (2021) 2021
life sciences & biomedicine (1989) 1989
levonorgestrel - administration & dosage (1724) 1724
levonorgestrel (1660) 1660
adult (1632) 1632
obstetrics & gynecology (1303) 1303
biological and medical sciences (1183) 1183
medical sciences (1156) 1156
birth control (869) 869
gynecology. andrology. obstetrics (807) 807
contraceptive agents, female - administration & dosage (770) 770
levonorgestrel - adverse effects (707) 707
adolescent (688) 688
pregnancy (636) 636
middle aged (561) 561
pharmacology. drug treatments (507) 507
contraception (501) 501
intrauterine devices, medicated (490) 490
population (478) 478
drug implants (407) 407
obstetrics and gynecology (401) 401
hormonal contraception (395) 395
oral contraceptives (372) 372
abridged index medicus (368) 368
levonorgestrel - pharmacology (365) 365
ethinyl estradiol - administration & dosage (350) 350
levonorgestrel - therapeutic use (345) 345
young adult (339) 339
contraceptive agents, female - adverse effects (337) 337
time factors (310) 310
norgestrel - administration & dosage (292) 292
genital system. reproduction (289) 289
prospective studies (289) 289
treatment outcome (276) 276
contraceptives, oral, combined - administration & dosage (259) 259
contraceptive drug implants (246) 246
reproductive biology (241) 241
intrauterine devices, medicated - adverse effects (210) 210
animals (205) 205
general & internal medicine (202) 202
medicine, general & internal (201) 201
pharmacology & pharmacy (195) 195
women (195) 195
follow-up studies (189) 189
dosage and administration (188) 188
health aspects (188) 188
united states (188) 188
other methods of contraception. sterilization (187) 187
contraceptives (186) 186
contraceptives, oral, combined - adverse effects (181) 181
emergency contraception (179) 179
intrauterine devices (175) 175
ethinyl estradiol (170) 170
ethinyl estradiol - adverse effects (170) 170
risk factors (168) 168
contraceptives, oral, combined - pharmacology (166) 166
endometrium - drug effects (163) 163
analysis (162) 162
ethinyl estradiol - pharmacology (160) 160
contraceptives, oral, synthetic - administration & dosage (159) 159
menorrhagia - drug therapy (157) 157
male (150) 150
administration, oral (148) 148
levonorgestrel - pharmacokinetics (144) 144
contraceptive agents, female - therapeutic use (142) 142
research (141) 141
contraception - methods (138) 138
levonorgestrel-releasing intrauterine system (136) 136
menstruation (134) 134
contraceptive agents, female - pharmacology (133) 133
norgestrel - pharmacology (133) 133
patient satisfaction (133) 133
estradiol - blood (126) 126
menorrhagia (126) 126
norgestrel - adverse effects (125) 125
estradiol - administration & dosage (120) 120
progestins - administration & dosage (120) 120
public, environmental & occupational health (119) 119
usage (118) 118
estradiol (117) 117
retrospective studies (114) 114
levonorgestrel - blood (112) 112
progesterone - blood (112) 112
progesterone congeners - administration & dosage (112) 112
delayed-action preparations (111) 111
contraceptive agents, female (108) 108
drug administration schedule (108) 108
intrauterine device (108) 108
womens health (106) 106
contraceptive drugs (105) 105
dose-response relationship, drug (105) 105
double-blind method (105) 105
social sciences (105) 105
desogestrel - administration & dosage (104) 104
endocrinology & metabolism (104) 104
contraception, postcoital - methods (103) 103
desogestrel (101) 101
clinical trials as topic (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3284) 3284
French (40) 40
Chinese (34) 34
German (28) 28
Spanish (17) 17
Danish (7) 7
Bulgarian (6) 6
Dutch (6) 6
Japanese (6) 6
Polish (6) 6
Portuguese (6) 6
Italian (4) 4
Russian (4) 4
Finnish (3) 3
Swedish (3) 3
Croatian (2) 2
Czech (2) 2
Hungarian (2) 2
Norwegian (2) 2
Persian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration–approved duration
by McNicholas, Colleen, DO, MSCI and Swor, Erin, MD and Wan, Leping, MPH and Peipert, Jeffrey F., MD, PhD
American journal of obstetrics and gynecology, ISSN 0002-9378, 2017, Volume 216, Issue 6, pp. 586.e1 - 586.e6
Obstetrics and Gynecology | effectiveness | prolonged use | implant | intrauterine device | Food and Drug Administration–approved duration | Body Mass Index | Prospective Studies | Desogestrel - adverse effects | United States | Humans | Middle Aged | Drug Implants | Intrauterine Devices, Medicated | Pregnancy | Young Adult | Desogestrel - administration & dosage | Time Factors | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Pregnancy, Unplanned | Adolescent | Adult | Female | Contraceptive Agents, Female | United States Food and Drug Administration | Cohort Studies | Contraceptive drug implants | Medical colleges | Medical research | Usage | Analysis | Levonorgestrel | Medicine, Experimental | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. food and drug administration-approved duration
by McNicholas, Colleen and Maddipati, Ragini and Zhao, Qiuhong and Swor, Erin and Peipert, Jeffrey F
Obstetrics and gynecology (New York. 1953), ISSN 0029-7844, 03/2015, Volume 125, Issue 3, pp. 599 - 604
Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Prospective Studies | United States | Humans | Contraceptive Agents, Female - administration & dosage | Intrauterine Devices, Medicated | Young Adult | Desogestrel - administration & dosage | Time Factors | Levonorgestrel - administration & dosage | Adolescent | Adult | Female | United States Food and Drug Administration | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy
by Ugaonkar, Shweta R and Wesenberg, Asa and Wilk, Jolanta and Seidor, Samantha and Mizenina, Olga and Kizima, Larisa and Rodriguez, Aixa and Zhang, Shimin and Levendosky, Keith and Kenney, Jessica and Aravantinou, Meropi and Derby, Nina and Grasperge, Brooke and Gettie, Agegnehu and Blanchard, James and Kumar, Narender and Roberts, Kevin and Robbiani, Melissa and Fernández-Romero, José A and Zydowsky, Thomas M
Journal of controlled release, ISSN 0168-3659, 09/2015, Volume 213, pp. 57 - 68
Efficacy | Core–matrix design | Contraception | Multipurpose prevention technology | Microbicides | Intravaginal ring | Core-matrix design | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Contraceptive Agents, Female - pharmacology | HIV Infections - prevention & control | Drug Delivery Systems - instrumentation | Antiviral Agents - pharmacokinetics | Urea - pharmacokinetics | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Contraceptive Agents, Female - administration & dosage | Pyridines - pharmacokinetics | Administration, Intravaginal | Human papillomavirus 16 - drug effects | Macaca mulatta | Equipment Design | Herpes Genitalis - prevention & control | Levonorgestrel - pharmacokinetics | Carrageenan - pharmacology | Urea - analogs & derivatives | Zinc Acetate - administration & dosage | Contraceptive Agents, Female - pharmacokinetics | Female | Herpesvirus 2, Human - drug effects | Urea - administration & dosage | Cell Line | Antiviral Agents - pharmacology | Levonorgestrel - pharmacology | Pyridines - administration & dosage | HIV-1 - drug effects | Carrageenan - pharmacokinetics | Contraceptive Devices, Female - virology | Antiviral Agents - administration & dosage | Pregnancy | Animals | Levonorgestrel - administration & dosage | Papillomavirus Infections - prevention & control | Zinc Acetate - pharmacokinetics | Zinc Acetate - pharmacology | Pyridines - pharmacology | HeLa Cells | Urea - pharmacology | Carrageenan - administration & dosage | Prevention | Contraceptives | Carrageenin | Pregnant women | Elastomers | Liquefied natural gas | HIV (Viruses) | Warships | Index Medicus | intravaginal ring | multipurpose prevention technology | core-matrix design | contraception | microbicides | efficacy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Male contraception
by Chao, Jing, MD and Page, Stephanie T., MD, PhD and Anderson, Richard A., MD, PhD, FRCOG
Best practice & research. Clinical obstetrics & gynaecology, ISSN 1521-6934, 2014, Volume 28, Issue 6, pp. 845 - 857
Obstetrics and Gynecology | spermatogenesis | testis | testosterone | contraception | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Oligospermia - chemically induced | Sperm Count | Antispermatogenic Agents - administration & dosage | Humans | Drug Implants | Male | Administration, Cutaneous | Testosterone - analogs & derivatives | Contraceptives, Oral, Synthetic - administration & dosage | Estrenes - administration & dosage | Adamantane - administration & dosage | Adamantane - analogs & derivatives | Azoospermia - chemically induced | Contraception - methods | Gels - administration & dosage | Clinical Trials as Topic | Injections, Intramuscular | Evidence-Based Medicine | Androgens - administration & dosage | Contraceptive Agents, Male - administration & dosage | Desogestrel - administration & dosage | Testosterone - administration & dosage | Animals | Vasectomy | Levonorgestrel - administration & dosage | Progestins - administration & dosage | Analysis | Contraception | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Quantitative determination of levonorgestrel in beagle dog plasma after vaginal administration of intravaginal ring by high‐performance liquid chromatography–tandem mass spectrometry
by Liu, Zhenqi and Qiu, Shunchen and Gu, Yiqun and Ning, Meiying
Biomedical chromatography, ISSN 0269-3879, 12/2018, Volume 32, Issue 12, pp. e4367 - n/a
intravaginal ring | pharmacokinetic | LC–MS/MS | levonorgestrel | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Pharmacology & Pharmacy | Chemistry, Analytical | Science & Technology | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Drug Stability | Contraceptive Devices, Female | Administration, Intravaginal | Linear Models | Animals | Levonorgestrel - pharmacokinetics | Levonorgestrel - administration & dosage | Levonorgestrel - blood | Sensitivity and Specificity | Dogs | Female | Tandem Mass Spectrometry - methods | Contraceptive drug implants | Liquefied natural gas | Mass spectrometry | Analysis | High performance liquid chromatography | Levonorgestrel | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Interventions for emergency contraception
by Shen, Jie and Che, Yan and Showell, Emily and Chen, Ke and Cheng, Linan
Cochrane database of systematic reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD001324 - CD001324
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Norpregnadienes - adverse effects | Drug Administration Schedule | Intrauterine Devices, Copper - adverse effects | Contraceptives, Postcoital - adverse effects | Contraception, Postcoital - adverse effects | Humans | Estradiol - administration & dosage | Intrauterine Devices, Medicated - adverse effects | Norpregnadienes - administration & dosage | Randomized Controlled Trials as Topic | Pregnancy | Mifepristone - adverse effects | Levonorgestrel - administration & dosage | Levonorgestrel - adverse effects | Contraceptives, Postcoital - administration & dosage | Unsafe Sex | Estradiol - adverse effects | Female | Contraception, Postcoital - methods | Pregnancy Rate | Mifepristone - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
by Sangkomkamhang, Ussanee S and Sangkomkamhang, Ussanee S and Lumbiganon, Pisake and Pattanittum, Porjai
Cochrane library, 11/2020, Volume 2020, Issue 11, pp. CD008994 - CD008994
Leiomyoma | OTHER ENDOCRINE DISORDERS (E.G. CONGENITAL ADRENAL HYPERPLASIA) | Antineoplastic Agents, Hormonal | Menstruation | Premenopause | Leuprolide | Levonorgestrel | Fibroids | Tumor Burden | Intrauterine Devices, Medicated | Randomized Controlled Trials as Topic | Gynaecology | Uterine Neoplasms | Menstrual cycle disorders/oligo-amenorrhoea | Progestins | DISORDERS OF MENSTRUAL CYCLING / OLIGO-AMENORRHOEA IN ASSOCIATION WITH | Medroxyprogesterone Acetate | Medicine General & Introductory Medical Sciences | Infertility/subfertility | Lynestrenol | Reproductive & sexual health | Other | Uterine Neoplasms - pathology | Bias | Humans | Middle Aged | Leiomyoma - pathology | Menstruation - drug effects | Leuprolide - administration & dosage | Contraceptives, Oral - administration & dosage | Adult | Female | Norethindrone Acetate - administration & dosage | Goserelin - administration & dosage | Nandrolone - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Nandrolone - analogs & derivatives | Lynestrenol - administration & dosage | Desogestrel - administration & dosage | Tumor Burden - drug effects | Levonorgestrel - administration & dosage | Progestins - administration & dosage | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Medroxyprogesterone Acetate - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights